US Patent 9018161 Protease resistant insulin analogues
Patent 9018161 was granted and assigned to Novo Nordisk on April, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 14 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+434 characters)
Article
Patent abstract
The present invention relates to novel insulin analogues exhibiting resistance towards protease, wherein at least two amino acids are substituted and/or deleted relative to the parent insulin molecule. A method for the preparation of such insulin analogues, insulin preparations containing the insulin analogues of the invention and a method of treating diabetes mellitus using these insulin analogues is also provided.
Edits on 13 Sep, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09018161 Protease resistant insulin analogues US Patent 9018161 Protease resistant insulin analogues
Infobox
Patent Number
0901816100
Patent Number
901816100
Edits on 23 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
090181610
Date of Patent
April 28, 2015
0Patent Application Number
124421900
Date Filed
September 20, 2007
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
090181610
Date of Patent
April 28, 2015
0Patent Application Number
124421900
Date Filed
September 20, 2007
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 09018161 Protease resistant insulin analogues
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
09018161
Date of patent
April 28, 2015
Patent application number
12442190
Date Filed
September 20, 2007
Patent primary examiner
Find more entities like US Patent 9018161 Protease resistant insulin analogues
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
